DA
Andrey, Diego Olivier
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Synergistic activity of a KL51-depolymerase and a Sugarlandvirus bacteriophage against ST16 Klebsiella pneumoniae | Microbiology spectrum | 2025 | 17 | 35 | |||
| Klebsiella pneumoniae : ombre et lumière | Revue médicale suisse | 2025 | 39 | 1 | |||
| Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas | Journal of antimicrobial chemotherapy | 2025 | 55 | 72 | |||
| Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolates | European journal of clinical microbiology & infectious diseases | 2025 | 9 | 8 | |||
| Genomic characterization of plasmids harboring blaNDM-1, blaNDM-5, and blaNDM-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan | Microbiology spectrum | 2025 | 45 | 19 | |||
| A framework towards implementation of sequencing for antimicrobial-resistant and other health-care-associated pathogens | The Lancet. Infectious diseases | 2025 | 83 | 0 | |||
| Association of pathogenic determinants of Fusobacterium necrophorum with bacteremia, and Lemierre’s syndrome | Scientific reports | 2024 | 80 | 112 | |||
| Contributions of long-read sequencing for the detection of antimicrobial resistance | Pathogens | 2024 | 258 | 196 | |||
| In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022 | European journal of clinical microbiology & infectious diseases | 2024 | 58 | 121 | |||
| Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023 | European journal of clinical microbiology & infectious diseases | 2024 | 52 | 123 | |||
| Antibiotics’ collateral effects on the gut microbiota in the selection of ESKAPE pathogens | CMI communications | 2024 | 70 | 134 | |||
| Entérobactéries multirésistantes et voyage | Revue médicale suisse | 2024 | 96 | 4 | |||
| Mediastinitis caused by an NDM-1 Escherichia coli in a child with Dacron® Sano shunt after pulmonary atresia with ventricular septal defect surgery treated with combination of aztreonam-avibactam | International journal of antimicrobial agents | 2024 | 77 | 74 | |||
| Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates | Clinical microbiology and infection | 2024 | 102 | 1 | |||
| Carriage of third-generation cephalosporin-resistant and carbapenem-resistant Enterobacterales among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | 2024 | 130 | 83 | |||
| Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae | Journal of antimicrobial chemotherapy | 2024 | 85 | 8 | |||
| Antimicrobial resistance in Enterobacterales infections among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | 2024 | 104 | 271 | |||
| Lecture de l’antibiogramme dans un contexte de résistance aux antibiotiques | Revue médicale suisse | 2023 | 86 | 489 | |||
| Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside | Clinical microbiology and infection | 2023 | 80 | 272 | |||
| Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin | Journal of global antimicrobial resistance | 2023 | 86 | 197 | |||
| Antimicrobial resistance dissemination driven by Klebsiella pneumoniae: the role of high-risk clones and high-risk plasmids | 2023 | 125 | 225 | ||||
| Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae | Microbiology spectrum | 2022 | 122 | 200 | |||
| Changes in the gut bacterial communities in colon cancer surgery patients: an observational study | Gut pathogens | 2022 | 232 | 137 | |||
| Silent circulation of BKC-1-producing Klebsiella pneumoniae ST442: molecular and clinical characterization of an early and unreported outbreak | International journal of antimicrobial agents | 2022 | 95 | 95 | |||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 87 | 0 | |||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | 2022 | 230 | 53 | |||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 445 | 142 | |||
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases | Frontiers in immunology | 2022 | 203 | 76 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 241 | 115 | |||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 524 | 320 | |||
| Prevalence of immunoglobulin G (IgG) against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) andeEvaluation of a rapid MEDsan IgG test in children seeking medical care | Clinical Infectious Diseases | 2021 | 300 | 265 | |||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 302 | 275 | |||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 407 | 216 | |||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | 2021 | 349 | 238 | |||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | 2021 | 646 | 167 | |||
| Vertical and horizontal dissemination of an incC plasmid harbouring rmtb 16s rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae | Journal of global antimicrobial resistance | 2021 | 258 | 224 | |||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | 2021 | 341 | 196 | |||
| A new mutation in mgrb mediating polymyxin resistance in Klebsiella variicola | International journal of antimicrobial agents | 2021 | 87 | 246 | |||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | 2020 | 457 | 407 | |||
| An Emerging Clone, Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae Sequence Type 16, Associated With High Mortality Rates in a CC258-Endemic Setting | Clinical infectious diseases | 2020 | 104 | 60 | |||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | 2020 | 379 | 201 | |||
| Insights into the global effect on Staphylococcus aureus growth arrest by induction of the endoribonuclease MazF toxin | Nucleic Acids Research | 2020 | 442 | 287 | |||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | 2020 | 269 | 109 | |||
| Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone | mSphere | 2020 | 206 | 322 | |||
| Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi centre cohort study | Transplant International | 2018 | 532 | 387 | |||
| Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals | European Journal of Clinical Microbiology & Infectious Diseases | 2017 | 678 | 244 | |||
| Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient | International journal of infectious diseases | 2017 | 621 | 178 | |||
| Rifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureus | Journal of bacteriology | 2016 | 622 | 1 | |||
| Re-emergence of scarlet fever: old players return? | Expert review of anti-infective therapy | 2016 | 499 | 1 | |||
| Clinical and epidemiological differences between implant-associated and implant-free orthopaedic infections | European journal of orthopaedic surgery & traumatology | 2016 | 555 | 0 | |||
| Xpert(®) MTB/RIF assay sensitivity with different methods of CSF processing for the diagnosis of TB meningitis | The international journal of tuberculosis and lung disease | 2015 | 526 | 426 | |||
| Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus | PloS one | 2015 | 669 | 608 | |||
| The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus | Antimicrobial agents and chemotherapy | 2012 | 754 | 482 | |||
| Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance | Antimicrobial agents and chemotherapy | 2011 | 728 | 0 | |||
| Molecular regulation of tst superantigen expression by global regulatory systems in Staphylococcus aureus | 2011 | 776 | 909 | ||||
| Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus | PloS one | 2011 | 704 | 625 | |||
| Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus | Journal of bacteriology | 2011 | 628 | 1 | |||
| Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA | Journal of bacteriology | 2010 | 661 | 0 | |||
| Use of serum antistreptolysin O titers in the microbial diagnosis of orthopedic infections | International journal of infectious diseases | 2009 | 650 | 0 |
